|
Jim Pickett
Jim Pickett, a long-time AIDS advocate and activist, is the advocacy director at AIDS Foundation of Chicago, championing sound, sane policy and fighting for adequate resources at the local, state, national and international levels. He chairs the global advocacy network IRMA - International Rectal Microbicide Advocates, and leads a gay men's health collaborative project in Chicago, addressing gay men's health in a holistic, assets-based fashion, inspired by his work with the Gay Men's Health Movement. Last year, he had the pleasure of co-chairing the 2009 National LGBTI Health Summit - the fourth of its kind - in Chicago. He has been HIV-positive since 1995, and ran four marathons between 2004 and 2007 in the service of raising funds for HIV/AIDS care and prevention services. Now it seems the only time he runs is when he hears the words "cookies" or "pie"-perhaps a side-effect of (finally) settling down with Mr. Wonderful.
Eric S. Daar, M.D.
Dr. Daar is Chief, Division of HIV Medicine at Harbor-UCLA Medical Center and Professor at the David Geffen School of Medicine, UCLA. He received his medical degree from Georgetown University and completed his residency in internal medicine and fellowship in Infectious Diseases at Cedars-Sinai Medical Center. Dr. Daar is an active clinician-investigator and author of more than 280 peer reviewed scientific articles and abstracts. His research interests relate to the management of HIV-1 infection and its complications and the immunopathogenesis of primary and chronic HIV-1 infection. He is a member of the Editorial Board and a reviewer for many scientific journals, serves as Vice Chair of the AIDS Clinical Trials Group Optimization of Antiretroviral Therapy Scientific Committee, is Chair of the NIH Prevention Trials Data Safety Monitoring Board and is a panel member of the United States Health and Human Services Guidelines Panel for Antiretroviral Therapy for Adults and Adolescents.
Dr. Calvin Cohen
Calvin J. Cohen, M.D., M.Sc. is the Research Director of both Community Research Initiative of New England and Harvard Vanguard Medical Associates. He is a Clinical Instructor at Harvard Medical School. Dr. Cohen earned his B.A. from Cornell University, his M.D. from the Albert Einstein College of Medicine, and his M.Sc. from the Harvard School of Public Health. He completed his medicine residency at Boston's Beth Israel Hospital, and a general medical fellowship at Harvard Medical School. Dr. Cohen's research focuses on HIV antiviral trials. He is a member of the Executive Committee of the INSIGHT network, an NIH-supported network of clinician-researchers. Dr. Cohen is published in Annals of Internal Medicine and the New England Journal of Medicine. He received the Outstanding Physician's Award by Harvard Vanguard Medical Associates, the Ebert Teaching award by Harvard Pilgrim Health Care, and the Community Recognition Award from the AIDS Action Committee of Massachusetts.
Professor Alan Whiteside
Alan Whiteside is the Director and Professor, Health Economics and HIV/AIDS Research Division (HEARD) which he established in 1998, at the University of KwaZulu-Natal, Durban. He has been involved in researching HIV/AIDS for over twenty years. Recent books include HIV/AIDS: A Very Short Introduction (Oxford University Press), 2008, and (with Tony Barnett), AIDS in the twenty-first century: disease and globalization (Palgrave), 2006 (2nd edition). Fellowships include a Leverhulme Visiting Professor, University of Southampton (2004-2006) and a Distinguished Visiting Fellow, Faculty of Arts and Social Science, Carleton University Canada [March 2009). He was appointed a Commissioner on the UN Commission on HIV/AIDS and Governance in Africa between 2003 and 2006. He is a member of the editorial boards of African Journal of AIDS Research; Development Policy Review; Globalisation and Health and Journal of the International AIDS Society. He is an elected member of the Governing Council of the International AIDS Society and a member of the Waterford Kamhlaba College Governing Council.
Mark B. Feinberg, M.D., Ph.D, FACP
Mark Feinberg currently serves as Vice President for Medical Affairs and Policy for Merck Vaccines and Infectious Diseases at Merck & Co., Inc. Dr. Feinberg earned his BA from the University of Pennsylvania, his MD and PhD degrees from Stanford University, pursued postgraduate medical training at the Brigham and Women's Hospital of Harvard University, and served as a postdoctoral fellow with Dr. David Baltimore at the Whitehead Institute for Biomedical Research. Prior to joining Merck in 2004, Dr. Feinberg worked for over 20 years in academia and government where he was actively engaged in basic and clinical research, patient care and health policy--with a primary focus on HIV/AIDS pathogenesis, treatment and prevention research. Dr. Feinberg is a Fellow of the American College of Physicians and the recipient of an Elizabeth Glaser Scientist Award from the Pediatric AIDS Foundation. Dr. Feinberg is a member of the Council on Foreign Relations, the National Vaccine Advisory Committee (NVAC), the IOM Forum on Microbial Threats, the External Advisory Board of the HIV Vaccine Trials Network (HVTN), the Board of Directors of the African Comprehensive HIV/AIDS Partnerships, and the Board of Trustees of the National Foundation for Infectious Diseases (NFID).
Dr. Michael L. Tan
Dr. Michael L. Tan is a medical anthropologist. He is currently professor at the College of Social Sciences and Philosophy, University of the Philippines in Diliman, Quezon City and head of the Medical Anthropology Unit of the University of the Philippines’ College of Medicine. He also lectures at the Ateneo School of Medicine and Public Health. Besides teaching, he has worked with non-government organizations since the 1970s, mainly around community-based health programs. He has been involved in HIV/AIDS programs since 1990, and served in the government’s Philippine National AIDS Council from 1995 to 2000. From 2001 to 2010 he served as the country adviser for the David and Lucile Packard Foundation, which mainly supported reproductive health programs in the Philippines. His most recent projects have included looking into benchmarks of fairness in health programs, folk illnesses, young adult sexuality and, currently, a project on HIV risks among Filipino men who have sex with men.
|
